Inovio Pharmaceuticals Inc (INO)

[biovalidator]

2015 should be a good year. We will see journal published HPV Phase II results. HIV launch with US government funding and the CEO said there will be some partnerships with Big Pharma. We also are waiting to find out about the ebola trial which is supposed to launch in January with Korean partner. We will also see Hepatitis C data with the Korean partner, Geneone. Be on the look out for gains in Korea. We could see some sort of hTERT, Aerodigestive, Head and Neck or Cervical cancer interim data, if good INO could make and hold gains. The Hepatitis B trial should start with Roche in 2015. Additionally I think we see the Monoclonal Antibody partnership with MedImmune and DARPA progress. Lastly, the Clostridium difficile (C. diff) DNA vaccine with Drexel/UPenn should gain some ground. Without a doubt, INO has a lot of irons in the fire.

Caveat - We could see dilution if INO goes alone for Phase III VGX.

Here is the fisrt quarter conference schedule:
Monday, January 12, 2015 Biotech Showcase San Francisco, California

Monday, January 26, 2015 Vaccine World East Asia 2015 South Korea

Monday, February 9, 2015 BIO CEO 2015 New York, New York

Tuesday, April 7, 2015 World Vaccine Congress - 2015

GL happy new year to all!